Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of CL22205 on Bone Mineral Density and Menopausal Symptoms in Women: A Randomized, Double-blind, Placebo Controlled Clinical Trial

NCT06899243 is registered in ClinicalTrials.gov with Eetho Brands, Inc as lead sponsor.

NCT NCT06899243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06899243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of CL22205 on Bone Mineral Density and Menopausal Symptoms in Women: A Randomized, Double-blind, Placebo Controlled Clinical Trial
Lead sponsor
Eetho Brands, Inc
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 25, 2025
Completion date
August 30, 2026
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

menopausal symptoms